Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard
News | Magnetic Resonance Imaging (MRI)
Using MRI for Prostate Cancer Diagnosis Equals or Beats Current Standard

February 8, 2021 — The results of a Phase III randomized clinical trial have shown that when it comes to detecting ...

Time February 08, 2021
arrow
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.
News | Radiation Dose Management
New Imaging Intellectual Property for Lower Radiation Dose

February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND ...

Time February 05, 2021
arrow
News | Prostate Cancer
Ultrasound Technique Treats Prostate Cancer with Minimal Side Effects

February 5, 2021 — A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance ...

Time February 05, 2021
arrow
 GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — announced the addition of a game-changing adaptive therapy, the Ethos.
News | Radiation Therapy
GenesisCare Brings Florida Cancer Patients First-of-its-Kind Ethos Adaptive Intelligence Technology

February 4, 2021 — GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the ...

Time February 04, 2021
arrow
Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti
News | PET Imaging
Imaging Identifies Breast Cancer Patients Unlikely to Benefit from Hormone Therapy

February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry ...

Time February 03, 2021
arrow
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab.
News | Radiation Therapy
Ludwig Cancer Research Study Reveals How Certain Gut Bacteria Compromise Radiotherapy

January 28, 2021 — A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of ...

Time January 28, 2021
arrow
Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT)
Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance

Janaury 25, 2021 —Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system ...

Time January 25, 2021
arrow
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.
News | Prostate Cancer
Radiation Boost Lowers Risk of Prostate Cancer Recurrence

January 25, 2021 — An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects ...

Time January 25, 2021
arrow
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.
Feature | Prostate Cancer | By Brian Wodlinger, Ph.D.
Detecting Prostate Cancer With Advanced Micro-ultrasound

Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next ...

Time January 20, 2021
arrow
The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD
News | Linear Accelerators
Dartmouth Researchers Pilot FLASH Radiotherapy Beam Development for Treatment of Cancer

January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris ...

Time January 20, 2021
arrow
Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging
News | PET Imaging
Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases

January 18, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time January 18, 2021
arrow
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH
News | Coronavirus (COVID-19)
Study Shows Sharp Decline in Cancer Screenings During First COVID-19 Surge

January 15, 2021 — In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses ...

Time January 15, 2021
arrow
The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to ResearchAndMarkets.com's offering. The prostate cancer nuclear medicine diagnostics market in the US was valued at $194.47M in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach $431.76M by 2027.
News | Prostate Cancer
US Prostate Cancer Nuclear Medicine Diagnostics Market Outlook

January 13, 2021 — The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast ...

Time January 13, 2021
arrow
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.
News | Prostate Cancer
MRI Frequently Underestimates Tumor Size in Prostate Cancer

January 11, 2021 — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic ...

Time January 11, 2021
arrow
Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions, announced that it has acquired Sun Nuclear Corporation. Sun Nuclear is the global leader in radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers around the world.
News | Quality Assurance (QA)
Mirion Technologies Acquires Sun Nuclear Corporation

January 8, 2021 — Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement ...

Time January 08, 2021
arrow
RAD Technology Medical Systems (RAD) announced it is expanding its portfolio of patented modular healthcare solutions in 2021 with the introduction of a compact shielding facility designed to accommodate the latest models of low energy, self-shielded linear accelerators (linacs) that are now available worldwide. 
News | Linear Accelerators
RAD Technology Medical Systems to Expand their Patented Modular Building Portfolio

January 4, 2021 — RAD Technology Medical Systems (RAD) announced it is expanding its portfolio of patented modular ...

Time January 04, 2021
arrow
RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.
News | Brachytherapy Systems
Brachytherapy Planning and a Speed Revolution in Proton Monte Carlo Dose Computation

December 29, 2020 — RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning ...

Time December 29, 2020
arrow
C-RAD has been selected as the partner to implement surface tracking technology for three proton cancer treatment centers in the U.S.
News | Proton Therapy
C-RAD Receives Order for Proton Cancer Treatment Centers in the U.S.

December 28, 2020 — C-RAD offers a specific version of its Catalyst System for use in proton and particle therapy - ...

Time December 28, 2020
arrow
A multidisciplinary team of researchers have demonstrated production, purification, and potential for the 134Ce/134La in vivo generator as a PET imaging surrogate for 225Ac and 227Th radiotherapeutic agents.
News | Nuclear Imaging
New Diagnostic Isotope to Enhance Targeted Alpha Therapy for Cancer

December 22, 2020 — Researchers in the DOE Isotope Program have developed an effective radionuclide, cerium-134, as a ...

Time December 22, 2020
arrow
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.
News | Radiation Therapy
Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic

December 21, 2020 — According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase ...

Time December 21, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now